ACS, Acute coronary syndrome; AF, Atrial fibrillation; AMI, Acute myocardial infarction; AUC, Area under the curve; Acute myocardial infarction; BMI, Body mass index; CAD, Coronary artery disease; CBA, Cytometric bead array; CHF, Chronic heart failure; CI, Confidence interval; CVD, Cardiovascular disease; Cytokine score; EFA, Exploratory factor analysis; ELISA, Enzyme-linked immunosorbent assay; GDF-15, Growth differentiation factor-15; GM-CSF, Granulocyte-macrophage colony-stimulating factor; HTN, Hypertension; IFNγ, Interferon gamma; IL-(number), Interleukin-(number); IQR, Interquartile range; Interleukin-6; Interleukin-8; MACE, Major adverse cardiovascular events; MCP-1, Monocyte chemoattractant protein-1; MFI, Mean fluorescence intensity; MI, Myocardial infarction; Major adverse cardiovascular events; NSTEMI, Non-ST elevation myocardial infarction; OR, Odds ratio; PCA, Principal component analysis; PCI, Percutaneous coronary intervention; Principal component analysis; RANTES, Regulated upon activation normal T-cell expressed and secreted; ROC, Receiver operator characteristic; STEMI, ST-elevation myocardial infarction; TGF-ß1, Tumour growth factor-beta 1; TIA, Transient ischaemic attack; TNF-α, Tumour necrosis factor alpha; TRAIL-R2, Tumour necrosis factor-related apoptosis-inducing ligand receptor 2; TnT, Troponin T; VEGF, Vascular endothelial growth factor; h, Hours; p, P-value